Trial Embedded in an Electronic Personal Medical Health Records
NCT00972348 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 338
Last updated 2013-11-20
Summary
This is a research study to determine if a personal health record, called myHERO, will help improve health. A personal health record is a secure internet (also called online) tool that contains personal health information like medications, diagnosed conditions, allergies and laboratory values (like CD4 cells and viral load). This study will also help explain if a personal health record influences the relationship with a doctor or nurse practitioner and their patients. The purpose of this study is to determine if a personal health record will influence health. The content of your personal health record is as secure as possible for any online health information.
Conditions
- HIV Infections
- Health Literacy
Interventions
- OTHER
-
Online access to a personal health record
Patients in the intervention arm have full access to their online personal health record
- OTHER
-
No access to the PHR
Patients will not be given access to their PHR but will complete online surveys.
Sponsors & Collaborators
-
University of California, San Francisco
lead OTHER
Principal Investigators
-
James Kahn, MD · University of California
-
David Thom, MD, PhD · University of California, San Francisco
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-07-31
- Primary Completion
- 2012-02-29
- Completion
- 2012-02-29
Countries
- United States
Study Locations
Related Clinical Trials
-
Advancing Dignity, Health, and Optimism in Connection With Long Acting Injectables
NCT05208541 · Status: RECRUITING
- HIV
-
Effects of Immunization With HIV-1 Immunogen Plus Anti-HIV Treatment Interruption on the Levels of HIV
NCT00021762 · Status: WITHDRAWN · Phase: PHASE2
- HIV Infections
-
Study of MK-1972 in Human Immunodeficiency Virus (HIV)-1 Infected Participants Who Have Not Previously Received Antiretroviral Therapy (MK-1972-003)
NCT01353898 · Status: TERMINATED · Phase: PHASE1
- HIV-1 Infection
-
Therapeutic Vaccination Followed by Treatment Interruption in HIV Infected Patients
NCT00058734 · Status: COMPLETED · Phase: PHASE1
- HIV Infections
-
A Clinical Trial to Evaluate the Safety and Immunogenicity of Glycan-trimmed HIV-1 Nanoparticle Vaccine (UVAX-1107), Followed by Homologous or Wild-type HIV-1 Nanoparticle Vaccine (UVAX-1197) Boost, Each Adjuvanted With 3M-052-AF + Alum in Adult Participants Without HIV
NCT06905275 · Status: SUSPENDED · Phase: PHASE1
- HIV-1-infection
More Related Trials
-
Study to Evaluate the Safety and Immunogenicity of an HIV-1 Vaccine Regimen of Adjuvanted UVAX-1107 Followed by Adjuvanted UVAX-1107 or Adjuvanted UVAX-1197 in Healthy Subjects Aged 25-55 Years.
NCT06541093 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Mesalamine to Reduce T Cell Activation in HIV Infection
NCT01090102 ·Status: COMPLETED ·Phase: PHASE4
-
Selection of a Protective T Cell-based HIV-1/FIV Vaccine
NCT02389595 ·Status: ACTIVE_NOT_RECRUITING
-
Efficacy of Adding Interleukin-2 to an Optimized Antiretroviral Regimen in HIV Patients in Therapeutic Failure (ANRS123)
NCT00113282 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Using Interleukin-2 in Antiretroviral Naïve HIV Patients (ANRS119)
NCT00120185 ·Status: COMPLETED ·Phase: PHASE2
-
Controlled Clinical Trial of Antiviral Cytotoxic T Lymphocyte (CTL) Infusion Following Combination Antiretroviral Drug Therapy for Asymptomatic HIV-1 Infection
NCT00000875 ·Status: TERMINATED ·Phase: NA
-
Analysis of Immune Responses to HIV Vaccines
NCT00068978 ·Status: COMPLETED
-
Evaluating the Safety and Immune Response to Three HIV Vaccine Schedules in Healthy, HIV-Uninfected Adults
NCT01783977 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Immune Response to Adjuvanted A(H1N1)v Influenza Vaccine in HIV-1 Infected and Immunosuppressed Adult Patients
NCT01017172 ·Status: UNKNOWN ·Phase: PHASE4
-
Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of 16055 NFL Delta Gly4 Env Protein Trimer and Trimer 4571 Combined With 3M-052-AF + Alum Adjuvant and Ad4-Env145NFL Viral Particles as Heterologous Prime-boost Regimens in Adult Participants Without HIV.
NCT06332339 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
The Effects of Anti-HIV Therapy on the Immune Systems of Children and Young Adults Infected With HIV
NCT00004735 ·Status: COMPLETED ·Phase: NA
-
Combinatorial Therapy to Induce an HIV Remission
NCT04357821 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Evaluating the Safety and Immune Response to an HIV Vaccine Boost Following the Administration of Two HIV Vaccines, in HIV-Uninfected, Healthy Adults (Study Extension to HVTN 073/SAAVI 102)
NCT01423825 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Effects of Interleukin-12 (rhIL-12) in HIV-Positive Patients With CD4 Cell Counts Less Than 50 Cells/mm3 or 300-500 Cells/mm3
NCT00000857 ·Status: COMPLETED ·Phase: PHASE1
-
Early Immune Responses to Vaccination - A Substudy to HVTN 205
NCT00908323 ·Status: COMPLETED
-
An International Study to Evaluate Recombinant Interleukin-2 in HIV Positive Patients Taking Anti-retroviral Therapy
NCT00004978 ·Status: COMPLETED ·Phase: PHASE3
-
The Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3
NCT00000825 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase II Study of Low-Dose Interleukin-2 by Subcutaneous Injection in Combination With Antiretroviral Therapy Versus Antiretroviral Therapy Alone in Patients With HIV-1 Infection and at Least 3 Months Stable Antiretroviral Therapy
NCT00000820 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Trial in Adult Participants Without HIV and in Overall Good Health to Evaluate the Safety and Immunogenicity of CD4BS CH505M5 Pr-NP1 Followed by CH505 TF chTrimer Boost Both Adjuvanted With Either Lipid Nanoparticles (LNPs) or 3M-052-AF + Alum
NCT06267872 ·Status: WITHDRAWN ·Phase: PHASE1
-
Study Evaluating Vaccine in Adults With HIV
NCT00195234 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Effectiveness of Immunotherapy With Autologous HIV-Specific CD8 Cells in HIV Infected Adults
NCT00110578 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluate Tolerability of a Multi-envelope, Prime-boost HIV Vaccine in Healthy Adults
NCT00623753 ·Status: TERMINATED ·Phase: PHASE1
-
Study Evaluating Vaccine in Adults With HIV
NCT00195312 ·Status: TERMINATED ·Phase: PHASE1
-
Safety and Immune Response to a Recombinant Adenovirus HIV-1 Vaccine in Healthy Adults
NCT00695877 ·Status: COMPLETED ·Phase: PHASE1
-
Safety of and Immune Response to Polyvalent HIV-1 Vaccine in HIV Uninfected Adults
NCT00061243 ·Status: UNKNOWN ·Phase: PHASE1